Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Oncology (Toronto, Ont.)
|
April 21, 2011
Rash rates with egfr inhibitors: meta-analysis
N Mittmann, S J Seung
Current Oncology (Toronto, Ont.)
|
September 9, 2020
Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
S J Seung, M Hurry, R N Walton, et al.
Current Oncology (Toronto, Ont.)
|
September 9, 2020
Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada
S J Seung, M Hurry, R N Walton, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
Cost-of-illness study for non-small-cell lung cancer using real-world data
S J Seung, M Hurry, S Hassan, et al.
Breast Cancer Research and Treatment
|
December 21, 2023
Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020
S J Seung, H Saherawala, D Moldaver, et al.
Current Oncology (Toronto, Ont.)
|
August 19, 2016
Radiation costing methods: a systematic review
F Rahman, S J Seung, S Y Cheng, et al.
Respiratory Medicine
|
December 19, 2007
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
N Mittmann, L Kuramoto, S J Seung, et al.
Current Oncology (Toronto, Ont.)
|
March 9, 2017
Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario
S Hassan, S J Seung, M C Cheung, et al.
Current Oncology (Toronto, Ont.)
|
June 4, 2020
A population-based analysis of breast cancer incidence and survival by subtype in Ontario women
S J Seung, A N Traore, B Pourmirza, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study
F Gwadry-Sridhar, S Nikan, A Hamou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Oncology (Toronto, Ont.)
|
April 21, 2011
Rash rates with egfr inhibitors: meta-analysis
N Mittmann, S J Seung
Current Oncology (Toronto, Ont.)
|
September 9, 2020
Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
S J Seung, M Hurry, R N Walton, et al.
Current Oncology (Toronto, Ont.)
|
September 9, 2020
Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada
S J Seung, M Hurry, R N Walton, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
Cost-of-illness study for non-small-cell lung cancer using real-world data
S J Seung, M Hurry, S Hassan, et al.
Breast Cancer Research and Treatment
|
December 21, 2023
Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020
S J Seung, H Saherawala, D Moldaver, et al.
Current Oncology (Toronto, Ont.)
|
August 19, 2016
Radiation costing methods: a systematic review
F Rahman, S J Seung, S Y Cheng, et al.
Respiratory Medicine
|
December 19, 2007
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
N Mittmann, L Kuramoto, S J Seung, et al.
Current Oncology (Toronto, Ont.)
|
March 9, 2017
Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario
S Hassan, S J Seung, M C Cheung, et al.
Current Oncology (Toronto, Ont.)
|
June 4, 2020
A population-based analysis of breast cancer incidence and survival by subtype in Ontario women
S J Seung, A N Traore, B Pourmirza, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study
F Gwadry-Sridhar, S Nikan, A Hamou, et al.
Page
of 2